Fig. 3From: Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancerPain/dysesthesia at end of treatment (a) and first follow-up (b; 6–8 weeks after treatment)Back to article page